Viewing Study NCT07052695


Ignite Creation Date: 2025-12-24 @ 2:01 PM
Ignite Modification Date: 2026-01-02 @ 7:57 AM
Study NCT ID: NCT07052695
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2025-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Mosunetuzumab for CLL MRD Clearance
Sponsor: Inhye Ahn
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module